Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -3.002% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1cc(=O)[nH]c(SCc2nc3ccc([N+](=O)[O-])cc3[nH]2)n1
b: COc1ccnc(Nc2ccc(C)c(C)c2)c1C#N
c: CCCCC1(C(=O)OCC)CC(CN2CCOCC2)OC1=O
Answer: c. CCCCC1(C(=O)OCC)CC(CN2CCOCC2)OC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCC1(C(=O)OCC)CC(CN2CCOCC2)OC1=O
CCCCC1(C(=O)OCC)CC(CN2CCOCC2)OC1=O
ethyl 3-butyl-5-(morpholin-4-ylmethyl)-2-oxooxolane-3-carboxylate